Found 15 matching trials
Antiviral Agents Against COVID-19 Infection PHASE2 A key strategy in the treatment of COVID-19 would be to find an effective a...
Show More Location
Hospital do Coracao
Learn More & Join Trial
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment PHASE2 The purpose of this study is to determine whether BMS-790052 added to Pegin...
Show More Location
Alabama Liver & Digestive Specialists (Alds)
Learn More & Join Trial
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C PHASE2 The purpose of this study is to evaluate the effectiveness of BMS-986094 an...
Show More Location
Local Institution
Learn More & Join Trial
Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients PHASE2 The purpose of this study is to identify at least 1 dose of daclatasvir tha...
Show More Location
Local Institution
Learn More & Join Trial
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 PHASE3 The purpose of this study is to determine if 24 weeks of treatment with Peg...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection PHASE2 To identify a shorter duration of antiviral therapy (12 or 16 weeks) for th...
Show More Location
California Liver Institute
Learn More & Join Trial
UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C PHASE3 The purpose of this study is to demonstrate that the proportion of treatmen...
Show More Location
Local Institution
Learn More & Join Trial
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C PHASE3 The purpose of this study is to compare the sustained virologic response at...
Show More Location
Scti Research Foundation
Learn More & Join Trial
Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin) PHASE2 The purpose of this study is to identify 1 or more doses of daclatasvir, wh...
Show More Location
Alabama Liver & Digestive Specialists (Alds)
Learn More & Join Trial
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin PHASE2 The purpose of this study is to determine if combination therapy with Pegyl...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial